Lifecorder: A new device for the long-term monitoring of motor activities for Parkinson's disease

25Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

Abstract

Objective. To quantitatively evaluate motor activity, its fluctuations, and drug effects in patients with Parkinson's disease (PD), the Lifecorder®, a new monitoring device, was attached to a group of patients for several weeks. This enabled the continuous recording of motor activity in ten scaled magnitudes at two-minute intervals for 6 weeks. Patients and Methods. Thirteen patients with PD who required dopamine receptor agonist therapy were monitored with Lifecorder, and seven healthy subjects served as the control group. The data obtained with this device correlated well with the Unified Parkinson's Disease Rating Scale (UPDRS) and Hoehn-Yahr grading. The dose of cabergoline, a D2-receptor agonist, was increased every 2 weeks, until optimum improvement was achieved. Results. By adding cabergoline, the mean UPDRS improved from 40.5 to 28.4, which was significant. In parallel, the mean daily walking count (WC) also increased from 2,459 to 3,315 steps (p<0.01) and movement-related calorie consumption (MCC) increased from 56 to 74 kcal (p<0.05). UPDRS thus correlated well with WC and MCC (p<0.05) obtained with this device. The improvement ratio of WC and MCC of each individual patient was compared with that of UPDRS. WC, and MCC shifted in parallel with UPDRS with one exception. The daily time-dependent fluctuation of motor activity was clearly shown by the Excel-generated graphs to improve with D-agonist therapy. In contrast to enhanced daytime activities, nocturnal restfulness was also clearly documented with this device. Conclusion. The unique properties of Lifecorder make this device a useful adjunct to the UPDRS for the objective evaluation of Parkinsonian motor activity. The device has a significant advantage over conventional clinical scales, as daytime as well as nocturnal motor activity can be objectively evaluated over long time periods ranging from one hour to one month, and the magnitude of motor activity is quantifiable in relation to the time-course.

References Powered by Scopus

Daytime sleepiness and other sleep disorders in Parkinson's disease

348Citations
N/AReaders
Get full text

Wrist actigraphy in insomnia

286Citations
N/AReaders
Get full text

Development of daytime somnolence over time in Parkinson's disease

150Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Long-term monitoring of gait in Parkinson's disease

176Citations
N/AReaders
Get full text

Light-intensity activities are important for estimating physical activity energy expenditure using uniaxial and triaxial accelerometers

101Citations
N/AReaders
Get full text

Data-driven based approach to aid Parkinson’s disease diagnosis

84Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Saito, N., Yamamoto, T., Sugiura, Y., Shimizu, S., & Shimizu, M. (2004). Lifecorder: A new device for the long-term monitoring of motor activities for Parkinson’s disease. Internal Medicine, 43(8), 685–692. https://doi.org/10.2169/internalmedicine.43.685

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 19

68%

Researcher 5

18%

Professor / Associate Prof. 4

14%

Readers' Discipline

Tooltip

Medicine and Dentistry 11

44%

Computer Science 6

24%

Engineering 5

20%

Agricultural and Biological Sciences 3

12%

Save time finding and organizing research with Mendeley

Sign up for free